May 22 (Reuters) - Ironwood Pharmaceuticals Inc said on Monday it would acquire Switzerland-based drug developer VectivBio Holding AG in a deal valued at about $1 billion, including debt. (Reporting by Raghav Mahobe in Bengaluru; Editing by Janane Venkatraman)
1st Jan change | Capi. | |
---|---|---|
+32.99% | 704B | |
+28.59% | 577B | |
-3.96% | 348B | |
+18.22% | 327B | |
+5.27% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.96% | 147B |